EntreMed commences ENMD-2076 Phase 2 study in triple-negative breast cancer - HER2 Support Group Forums

		HER2 Support Group Forums > General Cancer News
EntreMed commences ENMD-2076 Phase 2 study in triple-negative breast cancer

General Cancer News Latest Breast Cancer News from Moreover Technologies

Reply

07-25-2012, 05:50 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,104	EntreMed commences ENMD-2076 Phase 2 study in triple-negative breast cancer EntreMed, Inc., a clinical-stage pharmaceutical company, announced today the initiation of a dual-institutional Phase 2 study of ENMD-2076 in triple-negative breast cancer. Jennifer R. Diamond, MD at the University of Colorado serves as the principal investigator for the study. More...

Reply

« Previous Thread | Next Thread »

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Forum Rules

All times are GMT -7. The time now is 09:25 PM.

free webpage hit counter